How Solid Phase Peptide Synthesis Works

Solid phase peptide synthesis (SPPS) builds a peptide on an insoluble polymer while reagents and by-products stay in solution and are washed away. Merrifield’s original insight remains the reason milligram-to-multigram research peptides are practical: excess activated amino acid can be used to drive each coupling, then removed by filtration instead of a solution-phase isolation after every residue.

This article explains what happens in one cycle, why the resin is not a passive bead, and which incomplete reactions become the deletion peaks you later see on a chromatogram. It is written for scientists who order or troubleshoot peptides, not for a methods appendix. The manufacturing service that uses these cycles is described under custom peptide synthesis.

The solid support is part of the reaction

The C-terminal residue is attached to a functionalized resin through a linker. Linker chemistry decides whether cleavage yields a C-terminal acid or amide and how much acid is required to release the chain. Wang-type and related acid-labile esters are common for acids. Rink-type and related amide linkers are common for C-terminal amides. The loading (millimoles of first residue per gram of resin) sets the theoretical maximum amount of peptide. Overloading crowded chains; underloading wastes reactor volume.

Resin swelling in the synthesis solvent determines whether reagents reach interior sites. Polystyrene-based supports swell well in DMF and NMP and poorly in water. PEG-grafted or hydrophilic supports can help polar or aggregating sequences. If the bead does not swell, part of the growing chain is sterically hidden and couplings fail even when the supernatant looks fine.

Particle size and crosslinking affect diffusion. Fine resins increase surface area but can be harder to filter. Highly crosslinked beads are mechanically tougher and less swollen. None of these parameters appear on a typical CoA, yet they influence whether a hydrophobic 30-mer finishes as one main product or a family of deletions.

One Fmoc cycle, step by step

In Fmoc SPPS the temporary N-protecting group is 9-fluorenylmethoxycarbonyl. It is removed with a secondary amine, typically piperidine in DMF, generating dibenzofulvene that is trapped by the amine. The resin is washed until the deprotection mixture is gone. The next Fmoc-amino acid is activated—commonly as an aminium or phosphonium adduct with an additive such as HOBt, Oxyma, or HOAt—and added to the resin. After a set time, the resin is washed again. Optional capping with acetic anhydride blocks any remaining free amines so they cannot continue as deletion peptides in later cycles.

That loop repeats once per residue. A 20-mer is twenty deprotections and twenty couplings, plus the initial loading. Each step has a yield. A 99% stepwise yield sounds high until it is raised to the twentieth power. Small, repeated incompleteness is how SPPS produces the “ladder” of n−1 peptides that HPLC must later remove.

1. Swell the resin in the synthesis solvent and verify loading if the first residue was attached in a separate step.
2. Remove Fmoc with piperidine (or a substitute amine when piperidine is restricted), then wash.
3. Activate the incoming Fmoc-amino acid and couple; extend time or repeat for hindered residues.
4. Optionally cap residual amines.
5. Wash thoroughly so leftover activator does not travel into the next cycle.

Boc chemistry uses a different temporary group and a different deprotection acid, but the same solid-phase idea. The comparison is covered in Fmoc versus Boc peptide synthesis. Most research manufacturing today is Fmoc because the repeated deprotection is milder than repeated TFA on the growing chain.

Activation without treating reagents as magic

Carbodiimides, aminium salts, and phosphonium salts all convert a carboxylic acid into a species that an N-terminal amine can attack. They differ in racemization risk, by-product solubility, and how they behave with poorly nucleophilic amines. Hindered residues—Aib, N-methyl amino acids, β-branched isoleucine and valine, and some unnatural residues—need more reactive combinations or longer contact times. Arginine, with its bulky protecting groups, is a frequent slow coupler.

Racemization is a real side reaction at the activated carboxyl, especially for histidine, cysteine, and residues activated for too long before they meet the resin. Additives and short preactivation times are the usual controls. The CoA will not list enantiomeric purity unless a chiral method was run. If your biology is stereospecific, that limitation belongs in the project discussion.

Capping, aggregation, and deletion peptides

When a coupling is incomplete, two populations exist on the resin: chains that accepted the new residue and chains that did not. If you proceed, the shorter chains continue and become deletion sequences. Capping converts leftover amines to acetamides so they stop growing. Capped truncations are often easier to separate than near-full-length deletions that differ by one similar residue.

Aggregation is a physical problem. Hydrophobic or β-sheet-prone stretches associate on the resin, burying amines. Standard coupling times then fail. Chemists respond with better solvents, chaotropic additives, elevated temperature, microwave-assisted cycles, backbone protection (for example pseudoproline at Ser/Thr), or a change of resin. Sequence redesign—breaking a hydrophobic patch with a charged residue—is sometimes the more reliable fix. Those tactics overlap with difficult peptide synthesis.

SPPS problem	What you observe later	Typical process response
Incomplete coupling	n−1 deletion on HPLC/MS	Double couple, stronger activator, cap
Incomplete Fmoc removal	Truncation or insertion irregularities	Repeat deprotection, check piperidine quality
On-resin aggregation	Sudden drop in stepwise efficiency	Solvent change, backbone protection, heat
Aspartimide at Asp-Gly/Asn	β-aspartyl and piperidide products	Bulky Asp protection, milder base, backbone protection
Oxidation of Met/Cys/Trp	M+16 and related masses	Scavengers, inert atmosphere, careful cleavage

Cleavage is a second synthesis

The finished resin-bound peptide still carries side-chain protecting groups. Cleavage in TFA (Fmoc routes) or HF / strong acid (classical Boc routes) releases the chain and removes those groups. Scavengers—water, triisopropylsilane, thiols, or others matched to the residue set—trap cations that would otherwise alkylate Trp, Tyr, Met, or Cys. A cleavage cocktail copied from a generic protocol can leave tert-butyl or trityl remnants or create adducts that look like “mystery impurities” on LC-MS.

Precipitation into cold ether is common for isolating the crude peptide. The solid is washed, dried, and then purified, usually by reverse-phase HPLC. Crude quality at this stage already tells an experienced chemist whether the assembly worked. A chromatogram that is a forest of similar peaks is a synthesis problem, not a purification problem.

What SPPS does not automatically deliver

SPPS does not prove sequence order. It does not remove water or TFA from the lyophilized cake. It does not guarantee that a Cys-rich peptide has the intended disulfides. Those belong to oxidation protocols, analytical release, and, for rings, cyclic peptide work. SPPS is the chain-assembly engine. Everything after cleavage is a different set of decisions.

For research use, the practical question is whether the isolated main component matches the intended mass and is pure enough for the assay. If you need to specify that outcome, send the sequence through the same custom-synthesis path used for any other research peptide. Catalog sequences skip the design conversation only when the lot already exists.